Literature DB >> 8628356

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study.

S H Landesman1, L A Kalish, D N Burns, H Minkoff, H E Fox, C Zorrilla, P Garcia, M G Fowler, L Mofenson, R Tuomala.   

Abstract

BACKGROUND: A substantial proportion of perinatally acquired infections with the human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, which suggests that obstetrical factors may have an important influence on transmission. We evaluated the relation of such factors and other variables to the perinatal transmission of HIV-1.
METHODS: The Women and Infants Transmission Study is a prospective, observational study of HIV-1-infected women who were enrolled during pregnancy and followed with their infants for three years after delivery. We studied obstetrical, clinical, immunologic, and virologic data on 525 women who delivered live singleton infants whose HIV-1-infection status was known as of August 31, 1994.
RESULTS: Among mothers with membranes that ruptured more than four hours before delivery, the rate of transmission of HIV-1 to the infants was 25 percent, as compared with 14 percent among mothers with membranes that ruptured four hours or less before delivery. In a multivariate analysis, the presence of ruptured membranes for more than four hours nearly doubled the risk of transmission (odds ratio, 1.82; 95 percent confidence interval, 1.10 to 3.00; P = 0.02), regardless of the mode of delivery. The other maternal factors independently associated with transmission were illicit-drug use during pregnancy (odds ratio, 1.90; 95 percent confidence interval, 1.14 to 3.16; P = 0.01), low antenatal CD4+ lymphocyte count (<29 percent of total lymphocytes) (odds ratio, 2.82; 1.67 to 4.76; P<0.001), and birth weight <2500 g (odds ratio, 1.86; 1.03 to 3.34; P = 0.04).
CONCLUSIONS: The risk of transmission of HIV-1 from mother to infant increases when the fetal membranes rupture more than four hours before delivery.

Entities:  

Mesh:

Year:  1996        PMID: 8628356     DOI: 10.1056/NEJM199606203342501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

1.  Screening for HIV during pregnancy. Survey of physicians' practices.

Authors:  S E MacDonald; L A Hartling; R M Seguin; K S O'Connor; M L Rekart; D L Mowat; J R Hoey
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

Review 2.  Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.

Authors:  Athena P Kourtis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Care of the infant born to an HIV-positive mother.

Authors: 
Journal:  Paediatr Child Health       Date:  2000-04       Impact factor: 2.253

Review 4.  Mechanisms of resistance to HIV infection.

Authors:  W A Paxton; R A Koup
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Authors:  Kathryn Rough; Katherine Tassiopoulos; Deborah Kacanek; Raymond Griner; Ram Yogev; Kenneth C Rich; George R Seage
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

6.  Ten years of experience in the prevention of mother-to-child human immunodeficiency virus transmission in a university teaching hospital.

Authors:  Jung-Weon Park; Tae-Whan Yang; Yun-Kyung Kim; Byung-Min Choi; Hai-Joong Kim; Dae-Won Park
Journal:  Korean J Pediatr       Date:  2014-03-31

7.  Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.

Authors:  Kanchan Mukherjee
Journal:  Indian J Community Med       Date:  2010-01

8.  Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.

Authors:  Pierre Côté; Jean-Guy Baril; Marie-Nicole Hébert; Marina Klein; Richard Lalonde; Marc Poliquin; Danielle Rouleau; Rachel Therrien; Sylvie Vézina; Bernard Willems; Harold Dion; Patrice Junod; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Cécile Tremblay; Benoît Trottier; Sylvie Trottier; Chris Tsoukas; Alain Piché
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-09       Impact factor: 2.471

9.  Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa.

Authors:  Charles Chasela; Ying Qing Chen; Susan Fiscus; Irving Hoffman; Alicia Young; Megan Valentine; Lynda Emel; Taha E Taha; Robert L Goldenberg; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2008-03       Impact factor: 2.129

10.  Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.

Authors:  R E Dickover; E M Garratty; S Plaeger; Y J Bryson
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.